Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination
- 15 May 2006
- journal article
- research article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 111 (1-2) , 47-57
- https://doi.org/10.1016/j.vetimm.2006.01.008
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Equine viral vaccines: the past, present and futureVeterinary Research, 2004
- Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant maresVeterinary Immunology and Immunopathology, 2003
- Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytesJournal of General Virology, 2003
- Rabies DNA vaccine in the horse: strategies to improve serological responsesVaccine, 2003
- Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challengesVeterinary Microbiology, 2003
- Relative Potency of Cellular and Humoral Immune Responses Induced by DNA VaccinationIntervirology, 2000
- Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foalsVeterinary Microbiology, 1999
- An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal MuscleHuman Gene Therapy, 1996
- A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1Archiv für die gesamte Virusforschung, 1995
- Epizootiological Aspects of Type 1 and Type 4 Equine Herpesvirus Infections among Horse Populations.The Journal of Veterinary Medical Science, 1992